Discrepancies have been perceived in the NAWM of MS patients, showing not only increased PDE levels in CDMS patients [147], but also decreased levels in SPMS and RRMS patients [137,148], supporting the hypothesis of the impact of lesion localization and of neuro-axonal tracking failure in MS patients. Here, ALDH7A1 is linked to myeloid sarcoma.